M 
Mouwasat Medical Services Company SJSC 4002.SR · SAR
Health Care · Tadawul · 🇸🇦 Saudi Arabia
55.60
+1.09%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in SAR, from our data supplier.
Revenue
SAR 3.22bn
FY2016FY2025
Net income
SAR 822.0m
FY2016FY2025
Free cash flow
SAR 427.5m
FY2016FY2025
Shareholders' equity
SAR 3.78bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | SAR 3.22bn | SAR 2.88bn | SAR 2.71bn | SAR 2.33bn | SAR 2.14bn | SAR 2.05bn | SAR 1.86bn | SAR 1.68bn | SAR 1.51bn | SAR 1.24bn |
| Gross profit | SAR 1.36bn | SAR 1.29bn | SAR 1.29bn | SAR 1.10bn | SAR 995.8m | SAR 960.3m | SAR 829.3m | SAR 773.5m | SAR 712.2m | SAR 575.0m |
| Operating income | SAR 869.5m | SAR 724.3m | SAR 756.9m | SAR 663.1m | SAR 629.8m | SAR 577.8m | SAR 470.5m | SAR 411.4m | SAR 376.4m | SAR 300.5m |
| Net income | SAR 822.0m | SAR 645.8m | SAR 657.7m | SAR 599.3m | SAR 578.2m | SAR 528.2m | SAR 421.0m | SAR 360.2m | SAR 336.7m | SAR 255.9m |
| Diluted earnings per share | 4.55 | 3.24 | 3.29 | 3.00 | 5.37 | 5.28 | 2.11 | 1.80 | 1.68 | 1.28 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | SAR 5.99bn | SAR 5.40bn | SAR 4.96bn | SAR 4.66bn | SAR 4.06bn | SAR 3.65bn | SAR 3.52bn | SAR 3.05bn | SAR 2.48bn | SAR 2.10bn |
| Cash and short-term investments | SAR 497.5m | SAR 511.6m | SAR 149.0m | SAR 254.9m | SAR 256.9m | SAR 243.2m | SAR 294.6m | SAR 130.2m | SAR 201.8m | SAR 154.9m |
| Total liabilities | SAR 2.07bn | SAR 1.69bn | SAR 1.54bn | SAR 1.59bn | SAR 1.36bn | SAR 1.27bn | SAR 1.47bn | SAR 1.25bn | SAR 906.9m | SAR 737.1m |
| Debt | SAR 952.8m | SAR 761.7m | SAR 788.5m | SAR 892.2m | SAR 828.9m | SAR 783.4m | SAR 760.2m | SAR 681.4m | SAR 563.8m | SAR 466.0m |
| Shareholders' equity | SAR 3.78bn | SAR 3.57bn | SAR 3.28bn | SAR 2.92bn | SAR 2.60bn | SAR 2.28bn | SAR 1.96bn | SAR 1.71bn | SAR 1.49bn | SAR 1.29bn |
| Shares outstanding | 181m | 200m | 200m | 200m | 108m | 100m | 200m | 200m | 200m | 200m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | SAR 1.20bn | SAR 1.26bn | SAR 813.8m | SAR 707.3m | SAR 682.8m | SAR 482.5m | SAR 641.1m | SAR 385.8m | SAR 451.6m | SAR 306.4m |
| Capital spending | −SAR 773.4m | −SAR 435.6m | −SAR 286.5m | −SAR 298.7m | −SAR 330.2m | −SAR 233.7m | −SAR 270.6m | −SAR 311.9m | −SAR 300.0m | −SAR 241.1m |
| Free cash flow | SAR 427.5m | SAR 820.9m | SAR 527.2m | SAR 408.7m | SAR 352.6m | SAR 248.8m | SAR 370.5m | SAR 74.0m | SAR 151.5m | SAR 65.3m |
| Dividends paid | −SAR 600.0m | −SAR 350.0m | −SAR 300.0m | −SAR 275.0m | −SAR 250.0m | −SAR 200.0m | −SAR 175.0m | −SAR 150.0m | −SAR 125.0m | −SAR 100.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | SAR 876.4m | SAR 833.8m | SAR 884.6m | SAR 777.3m | SAR 796.4m | SAR 764.3m | SAR 755.5m | SAR 710.7m |
| Gross profit | SAR 356.4m | SAR 414.3m | SAR 334.3m | SAR 323.6m | SAR 356.4m | SAR 347.2m | SAR 317.8m | SAR 317.9m |
| Operating income | SAR 229.4m | SAR 207.0m | SAR 240.5m | SAR 212.2m | SAR 203.4m | SAR 213.3m | SAR 185.0m | SAR 167.8m |
| Net income | SAR 211.4m | SAR 201.0m | SAR 238.4m | SAR 199.7m | SAR 187.0m | SAR 197.0m | SAR 171.8m | SAR 149.6m |
| Diluted earnings per share | 1.06 | 1.01 | 1.32 | 1.10 | 1.03 | 1.09 | 0.86 | 0.75 |
| Cash from operations | SAR 16.0m | SAR 304.0m | SAR 369.0m | SAR 475.0m | SAR 74.0m | SAR 264.0m | SAR 444.0m | SAR 272.0m |
| Capital spending | −SAR 120.0m | −SAR 177.0m | −SAR 155.0m | −SAR 208.0m | −SAR 147.0m | −SAR 61.0m | −SAR 138.0m | −SAR 95.0m |
| Free cash flow | −SAR 104.0m | SAR 127.0m | SAR 214.0m | SAR 267.0m | −SAR 73.0m | SAR 203.0m | SAR 306.0m | SAR 177.0m |
| Total assets | SAR 6.62bn | SAR 6.53bn | SAR 5.99bn | SAR 5.91bn | SAR 5.55bn | SAR 5.64bn | SAR 5.40bn | SAR 5.37bn |
| Cash and short-term investments | — | — | SAR 497.5m | SAR 576.0m | SAR 326.2m | SAR 699.9m | SAR 511.6m | SAR 263.0m |
| Debt | SAR 932.6m | SAR 930.5m | SAR 952.8m | SAR 1.03bn | SAR 928.5m | SAR 776.2m | SAR 742.2m | SAR 783.0m |
| Shareholders' equity | SAR 3.97bn | SAR 3.98bn | SAR 3.78bn | SAR 3.75bn | SAR 3.55bn | SAR 3.77bn | SAR 3.57bn | SAR 3.40bn |
Financial ratios
Data as of 1 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 42.2% | 44.8% | 47.9% | 47.1% | 46.4% | 47.0% |
| Operating margin | 27.0% | 25.2% | 28.0% | 28.4% | 29.4% | 28.3% |
| Net margin | 25.5% | 22.4% | 24.3% | 25.7% | 27.0% | 25.8% |
| Return on equity | 21.8% | 18.1% | 20.1% | 20.5% | 22.2% | 23.2% |
| Return on assets | 13.7% | 12.0% | 13.2% | 12.9% | 14.2% | 14.5% |
| Free cash flow yield | 17.8% | 13.8% | 9.0% | 8.2% | 15.4% | 11.7% |
| Revenue growth | 11.9% | 6.4% | 15.9% | 8.9% | 4.8% | 10.1% |
| Earnings growth | 27.3% | -1.8% | 9.7% | 3.7% | 9.5% | 25.4% |
| Current ratio | 1.74x | 1.99x | 1.95x | 1.98x | 2.05x | 2.17x |
| Debt to equity | 0.25x | 0.21x | 0.23x | 0.30x | 0.31x | 0.33x |
| Equity ratio | 63.1% | 66.0% | 66.0% | 62.7% | 64.2% | 62.5% |
| Interest coverage | 44.47x | 23.78x | 16.29x | 28.98x | 76.81x | 41.16x |
| Buybacks as a share of market value | 9.4% | 0.2% | 0.0% | -85.9% | -7.6% | 50.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 11.4% | 9.5% | 12.4% |
| Operating income | 9.5% | 8.5% | 14.0% |
| Net income | 11.1% | 9.3% | 14.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 43.4% | 45.3% | 45.7% | 45.7% |
| Operating margin | 26.1% | 27.0% | 27.5% | 26.6% |
| Net margin | 24.1% | 24.5% | 25.0% | 23.9% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 14.7 | 26.3 | 34.0 | 34.9 | 16.2 | 13.1 | 20.9 | 22.4 | 22.5 | 28.7 |
| Price to sales | 3.7 | 5.9 | 8.3 | 8.9 | 4.4 | 3.4 | 4.7 | 4.8 | 5.0 | 5.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 16 years. Last went ex-dividend on 7 Dec 2025.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.00 | 2.00 | 1.75 | 2.875 | 1.25 | 1.00 | 0.875 | 0.75 |
- 2-for-1 split · 8 Aug 2023
- 2-for-1 split · 4 Jun 2018
- 2-for-1 split · 3 Apr 2012
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.